Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04851431 · ClinicalTrials.gov registry record · Phase 2
Effects of Peer Mentoring on Caregivers of Patients With Acquired Brain Injury
A Phase 2 study of Family Members and Acquired Brain Injury, sponsored by Shepherd Center, Atlanta GA.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04851431 is a Phase 2 study of Family Members and Acquired Brain Injury that has completed, run by Shepherd Center, Atlanta GA. The registered enrollment target is 41 participants, below the 539-participant average among 11 other Family Members trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04851431, a Phase 2 study of Family Members and Acquired Brain Injury, has completed, sponsored by Shepherd Center, Atlanta GA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
Family caregivers often take on the demands of long-term caregiving after ABI. Early efforts to prepare family caregivers for the caregiving role after discharge from acute ABI inpatient rehabilitation may be beneficial in many ways. This study will look at the impact of participation in a one-to-one peer mentor program on the use of family support services and caregivers' emotional health and well-being (depression symptoms, stress). Participants in this study will include caregivers of patient admitted to the Shepherd Center ABI inpatient rehabilitation unit. Caregivers will be randomly selected to participate in the one-to-one mentor program. The program will include visits with a peer mentor who is the caregiver of an individual with an acquired brain injury. Participants will be able to choose a peer mentor that matches their personal situation and preferences. They will meet with the peer mentor about once a week during the patient's stay at Shepherd Center and may continue with phone calls up to 30 days post-discharge. Participants will be asked to complete a brief evaluation after each peer mentor interaction to determine the value of the interactions and their interest in continuing visits. Participants will be asked to take part in three interviews that will last 10-15 minutes. The first will be within the first two weeks at Shepherd Center and the second will be a few days after discharge. A third interview will be conducted by phone about 30 days post discharge.
Conditions Studied
Interventions
- BEHAVIORAL one-to-one peer mentoring
Study Locations (1)
Georgia
- Shepherd Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-01-08 |
| Est. Completion | 2021-01-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04851431
The ClinicalTrials.gov registry entry for NCT04851431 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 539-participant average among 11 other Family Members trials with a reported enrollment target (92% lower). The listed sponsor is Shepherd Center, Atlanta GA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Family Members appearing as the primary indexed condition, and to 1 intervention - of which one-to-one peer mentoring is the first listed.
NCT04851431 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04851431 about?
NCT04851431 is a clinical study titled "Effects of Peer Mentoring on Caregivers of Patients With Acquired Brain Injury". Family caregivers often take on the demands of long-term caregiving after ABI. Early efforts to prepare family caregivers for the caregiving role after discharge from acute ABI inpatient rehabilitation may be beneficial in many ways. This study will look at the impact of participation in a one-to-on...
What is the current status of trial NCT04851431?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2019-01-08. Estimated completion is 2021-01-30.
What conditions does trial NCT04851431 study?
This clinical trial studies the following conditions: Family Members, Acquired Brain Injury.
What interventions are being tested in trial NCT04851431?
The interventions under investigation include: one-to-one peer mentoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT04851431?
This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04851431 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Family Members
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People At Risk for Alzheimer's Disease
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
RECRUITING · NA
-
FAmily Engagement Strategy for Coordinated Specialty Care
RECRUITING · NA
-
Family Peer Navigator for Early Psychosis for Black Families
RECRUITING · NA
-
Using Structured Video Chat to Improve Relationships Between Young Children and Remote Grandparents
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.